Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the effectiveness and safety of one dose of
botulinum toxin type A (Dysport) associated with rehabilitation treatment on pain control in
patients with a type of back pain called primary myofascial pain syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Ipsen
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA